Page 43 - 2016-2021-ASU
P. 43

radiology services and  review  the viability of pre-authorizing non-

         urgent/non-emergent cardiologic procedures and testing.

            (5) The Joint Committee on Health Benefits will work with the State and
         medical carrier  to solicit and  contract with  credentialed radiological

         providers to provide mammography screening, according to the American
         Cancer Society's medical protocols, at the worksite and/or predetermined

         location.  Reimbursement will  be provided  in accordance with  the
         participating provider program, subject to the diagnostic copayment.

             (6) The continuation of the ambulatory surgery benefit and monitoring
         of participating centers.  The Joint Committee on Health Benefits will work

         with  the State to oversee the  solicitation by  the medical/surgical/basic
         medical carrier of Ambulatory Surgical Centers in bordering states and in

         those states where retirees commonly reside.
             (7) The continuation of the Home Care Advocacy Program (HCAP) and

         the ongoing review of services offered. The JCHB shall work with the State
         to review and monitor the utilization of DME under HCAP, specifically

         requests, approvals and denials of duplicate equipment.  If necessary the
         State and CSEA Joint Committee will take appropriate action to address

         the issue.
            (8) The Joint Committee on Health Benefits will continue to review the

         impact of Domestic Partner coverage.
            (9) The Joint Committee on Health Benefits will work with the State to

         monitor and oversee the Specialty Pharmacy Program.
            (10) If reimportation of prescription drugs becomes permissible under

         applicable law, rule, regulation or other appropriate approval, the parties

         agree to work  through  the JCHB to explore the plan’s  use of such
         reimported drugs  and evaluate the overall  impact to  the Empire Plan
         Prescription Drug Program.  The parties will determine whether to

         recommend the implementation of the plan’s utilization of such drugs if

         both  parties agree  that  it is practicable, cost effective and able to be
         implemented into and become part of the current Empire Plan prescription

         drug program.  Implementation of the alternative drug program for CSEA-
         represented employees will not take place without the agreement of the

         CSEA JCHB.
            (11) The JCHB will work with the State and the Empire Plan prescription

         drug carriers to monitor and oversee the Enhanced Flexible Formulary.  No


                                                            42
   38   39   40   41   42   43   44   45   46   47   48